首页> 美国卫生研究院文献>Pathogens >Antimicrobial Resistance and Molecular Epidemiology of Corynebacterium striatum Isolated in a Tertiary Hospital in Turkey
【2h】

Antimicrobial Resistance and Molecular Epidemiology of Corynebacterium striatum Isolated in a Tertiary Hospital in Turkey

机译:土耳其一家三级医院分离的纹状棒状杆菌的抗药性和分子流行病学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although is part of the human flora, it has recently drawn attention both for its multidrug resistance and its role as an invasive infection/outbreak agent. This cross-sectional study aimed to determine the antimicrobial resistance and clonal relationships among strains. In total, 81 strains were identified using Phoenix-100 (BD, Sparks, MD, USA). The antimicrobial resistance of the strains was determined using the Kirby–Bauer disk diffusion method. Clonal relatedness among the strains was performed via arbitrarily primed polymerase chain reaction (AP-PCR). All 81 strains were resistant to penicillin, cefotaxime, ciprofloxacin, and tetracycline, but susceptible to vancomycin and linezolid. The resistance rates to gentamicin, erythromycin, and clindamycin were 34.6%, 79%, and 87.7% respectively. AP-PCR results showed no predominant clone among the strains. is reportedly the cause of an increasing number of invasive infections/outbreaks. Moreover, treatment options are limited. The study showed that vancomycin, linezolid, and gentamicin can be selected for the empirical treatment of infections. Although no single-clone outbreak was observed in our hospital, small clonal circulations were observed within some units, indicating cross-contamination. Therefore, a comprehensive infection control program is warranted in future.
机译:尽管它是人类菌群的一部分,但最近因其多重耐药性和作为侵入性感染/爆发剂的作用而受到关注。这项横断面研究旨在确定菌株之间的抗药性和克隆关系。使用Phoenix-100(BD,Sparks,MD,USA)总共鉴定出81个菌株。使用Kirby-Bauer圆盘扩散法确定了菌株的抗药性。菌株之间的克隆相关性是通过任意引发的聚合酶链反应(AP-PCR)进行的。所有81个菌株均对青霉素,头孢噻肟,环丙沙星和四环素具有抗性,但对万古霉素和利奈唑胺敏感。对庆大霉素,红霉素和克林霉素的耐药率分别为34.6%,79%和87.7%。 AP-PCR结果显示菌株之间没有优势克隆。据报道,这是侵入性感染/爆发数量增加的原因。而且,治疗选择是有限的。研究表明,可以选择万古霉素,利奈唑胺和庆大霉素来进行感染的经验治疗。尽管在我们医院未观察到单克隆暴发,但在某些单位内仍观察到小的克隆循环,表明存在交叉污染。因此,将来需要全面的感染控制程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号